Award for leading Spanish ophthalmologist

Article

Dr Jorge Alio, a valued member of Ophthalmology Times Europe?s Editorial Advisory Board, has been acknowledged by The Cornea Research Foundation of America (CRFA) for his technique using Yag laser treatments to eliminate epithelial ingrowth after Lasik.

Dr Jorge Alió, a valued member of Ophthalmology Times Europe’s Editorial Advisory Board, has been acknowledged by The Cornea Research Foundation of America (CRFA) for his technique using Yag laser treatments to eliminate epithelial ingrowth after Lasik.

The Torchbearer Award, presented to Dr Alió, during the ESCRS meeting in Barcelona recognizes individuals whose lifetime service and commitment to the field of vision care has helped light the way for others. It was developed by CRFA Founder Dr Francis W. Price, Jr., MD to recognize dedicated ophthalmic research physicians throughout the world.

The award was made for Dr Alió's work on the development of a non-invasive method to treat glare and halos post laser surgery. According to the CRFA, Epithelial cells rarely grow into the interface between the Lasik flap and underlying stromal bed after primary procedures. However, after re-treatments, where Lasik flaps are lifted and replaced, epithelial ingrowth can occur in up to 5-10% of cases. Dr Alió's innovative treatment creates a dramatic improvement in this condition. Previously flaps had to be re-lifted to remove the cells. The epithelial ingrowth could recur after its removal, and in some cases the Lasik flaps would require suturing down to prevent the epithelial cells from returning. Now with the use of the YAG laser, there are no more flap lifts or sutures to correct this condition providing better outcomes and more comfortable treatments for patients.

To learn more about the Foundation visit www.cornea.org

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.